Terence Khoo

1PUBLICATIONS
1CO-AUTHORS
Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Nov 05, 2020
Cost-effectiveness of osimertinib versus standard EGFR-TKI as first-line treatment for locally advanced or metastatic EGFR mutation-positive non-small cell lung cancer in Australia.

Terence Khoo, Lan Gao

Pageof 1

Frequent Collaborators

1 joint publications

Lan Gao